- Home
- STRO vs TGE Comparison
STRO vs TGE Comparison
Compare STRO & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- TGE
- Stock Information
- Founded
- STRO 2003
- TGE 2023
- Country
- STRO United States
- TGE France
- Employees
- STRO N/A
- TGE N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- TGE Newspapers/Magazines
- Sector
- STRO Health Care
- TGE Consumer Discretionary
- Exchange
- STRO Nasdaq
- TGE Nasdaq
- Market Cap
- STRO 94.9M
- TGE 85.8M
- IPO Year
- STRO 2018
- TGE N/A
- Fundamental
- Price
- STRO $0.95
- TGE $1.16
- Analyst Decision
- STRO Hold
- TGE
- Analyst Count
- STRO 7
- TGE 0
- Target Price
- STRO $1.97
- TGE N/A
- AVG Volume (30 Days)
- STRO 1.6M
- TGE 12.0M
- Earning Date
- STRO 11-10-2025
- TGE 10-20-2025
- Dividend Yield
- STRO N/A
- TGE N/A
- EPS Growth
- STRO N/A
- TGE N/A
- EPS
- STRO N/A
- TGE N/A
- Revenue
- STRO $104,473,000.00
- TGE $130,212,000.00
- Revenue This Year
- STRO $65.48
- TGE N/A
- Revenue Next Year
- STRO N/A
- TGE N/A
- P/E Ratio
- STRO N/A
- TGE $2.93
- Revenue Growth
- STRO N/A
- TGE 81.03
- 52 Week Low
- STRO $0.52
- TGE $0.78
- 52 Week High
- STRO $4.60
- TGE $37.02
- Technical
- Relative Strength Index (RSI)
- STRO 45.59
- TGE N/A
- Support Level
- STRO $1.01
- TGE N/A
- Resistance Level
- STRO $1.20
- TGE N/A
- Average True Range (ATR)
- STRO 0.12
- TGE 0.00
- MACD
- STRO -0.02
- TGE 0.00
- Stochastic Oscillator
- STRO 8.09
- TGE 0.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.